Wiltrom Co., Ltd.
Wiltrom Co., Ltd. researches, develops, manufactures, and sells a range of implantable medical devices in Taiwan and internationally. The company's products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. The company was founded in 2009 and is based in Zhubei, Taiwan.
Market Cap & Net Worth: Wiltrom Co., Ltd. (6767)
Wiltrom Co., Ltd. (TWO:6767) has a market capitalization of $7.95K (NT$262.88K) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #45246 globally and #2009 in its home market, demonstrating a -1.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Wiltrom Co., Ltd.'s stock price NT$29.00 by its total outstanding shares 9065 (9.06K).
Wiltrom Co., Ltd. Market Cap History: 2025 to 2026
Wiltrom Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $7.64K to $7.95K (0.00% CAGR).
Wiltrom Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Wiltrom Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6767 by Market Capitalization
Companies near Wiltrom Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Wiltrom Co., Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Wiltrom Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Wiltrom Co., Ltd.'s market cap moved from $7.64K to $ 7.95K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$7.95K | +3.94% |
| 2025 | NT$7.64K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Wiltrom Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.95K USD |
| MoneyControl | $7.95K USD |
| MarketWatch | $7.95K USD |
| marketcap.company | $7.95K USD |
| Reuters | $7.95K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.